awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53752984-4C5F652A-B51B-4A16-886E-D55FCF42C698
Q53752984-4C5F652A-B51B-4A16-886E-D55FCF42C698
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53752984-4C5F652A-B51B-4A16-886E-D55FCF42C698
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).
P921
Q53752984-4C5F652A-B51B-4A16-886E-D55FCF42C698
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53752984-4C5F652A-B51B-4A16-886E-D55FCF42C698
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
chemotherapy